GASTRIN PATHOPHYSIOLOGY - ANTISECRETORY DRUGS

被引:0
|
作者
DELLEFAVE, G [1 ]
ANNIBALE, B [1 ]
DEMAGISTRIS, L [1 ]
机构
[1] UNIV ROME LA SAPIENZA,CATTEDRA GASTROENTEROL 1,I-00185 ROME,ITALY
来源
ITALIAN JOURNAL OF GASTROENTEROLOGY | 1990年 / 22卷
关键词
GASTRIN; GASTRIC ACID SECRETION; ANTISECRETORY DRUGS;
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
The management of maintenance therapy in peptic disease (oesophagus, stomach, duodenum) with antisecretory drugs should keep in consideration the aspect of developing hypergastrinemia: gastrin exerts a throphic effect on gastric ECL and parietal cells. After a long term maintenance therapy (3-5) years) with ranitidine 150mg/die in a group of 55 patients affected by duodenal ulcer, 20% of them developed hypergastrinemia and gastric hypersecretion (evaluated after one week of drug withdrawal). The same 20% of the subjects showed increased relapse rates with respect to those who did develop the same gastrin/gastric acid increase.
引用
收藏
页码:32 / 35
页数:4
相关论文
共 50 条
  • [31] Antisecretory or only antibacterial drugs in the treatment of peptic ulcers
    Oderda, G
    DeGiacomo, C
    RIVISTA ITALIANA DI PEDIATRIA-ITALIAN JOURNAL OF PEDIATRICS, 1995, 21 (04): : 429 - 431
  • [32] INFLUENCE OF THE DEGREE OF SEVERITY OF FUNDIC GASTRITIS ON SERUM GASTRIN-CONCENTRATION AND ECL CELL-DENSITY IN CONTROLS AND DURING PROLONGED TREATMENT WITH ANTISECRETORY DRUGS
    DIEBOLD, MD
    RICHARDSON, S
    ZEITOUN, P
    DUCHATEAU, A
    BIGARD, MA
    COLIN, R
    CORTOT, A
    GASTROENTEROLOGY, 1995, 108 (04) : A83 - A83
  • [33] Adaptation to the antisecretory effect of YF476, a new gastrin antagonist, in healthy men
    Boyce, M
    Warrington, S
    Lewis, Y
    Nentwich, H
    Harris, A
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2002, 53 (04) : 437P - 437P
  • [34] ANTISECRETORY AND SERUM GASTRIN LOWERING EFFECT OF ENPROSTIL IN PATIENTS WITH DUODENAL-ULCER DISEASE
    MAHACHAI, V
    WALKER, K
    SEVELIUS, H
    THOMSON, ABR
    GASTROENTEROLOGY, 1985, 89 (03) : 555 - 561
  • [35] Gastro-esophageal reflux through gastric antisecretory drugs
    Jian, R.
    GASTROENTEROLOGIE CLINIQUE ET BIOLOGIQUE, 2009, 33 (8-9): : 614 - 624
  • [36] Gastric transmucosal potential difference:: Effect of antisecretory and gastroprotective drugs
    Nosál'ová, V
    Babul'ová, A
    Bauer, V
    GENERAL PHARMACOLOGY-THE VASCULAR SYSTEM, 1998, 30 (03): : 325 - 329
  • [37] PHARMACOLOGICAL ASSESSMENTS OF ANTISECRETORY DRUGS IN MAN - THE ROLE OF INTRAGASTRIC PHMETRY
    GALMICHE, JP
    DESVARANNES, SB
    THERAPIE, 1992, 47 (02): : 97 - 98
  • [38] Clinical Use of Gastric Antisecretory Drugs in Hospitalized Pediatric Patients
    Locci, Cristian
    Cuzzolin, Laura
    Cheri, Gianluca
    Saderi, Laura
    Sotgiu, Giovanni
    Antonucci, Roberto
    JOURNAL OF CLINICAL MEDICINE, 2023, 12 (01)
  • [39] DIFFERENT MECHANISMS OF 2 POTENT ANTISECRETORY DRUGS - CIMETIDINE AND PROSTAGLANDINS
    SIMON, B
    KATHER, H
    MEDIZINISCHE WELT, 1978, 29 (29-3): : 1182 - 1183
  • [40] EFFECT OF ANTISECRETORY DRUGS ON EXPERIMENTALLY INDUCED WEANLING DIARRHEA IN PIGLETS
    COX, E
    COOLS, V
    HOUVENAGHEL, A
    VETERINARY RESEARCH COMMUNICATIONS, 1989, 13 (02) : 159 - 170